ZIOPHARM Oncology, Inc. (WEK)
Market Closed
17 Jul, 20:00
XMUN XMUN Primary €
149. 25
0
0%
€
329.22M Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.6 Eps
€ 149.25
Previous Close Want to track WEK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ZIOPHARM Oncology, Inc. (WEK) Statistics
Valuation metrics
Market Cap 329.22M
Enterprise value -
Trailing P/E (ttm) -67.84
Forward P/E -
PEG ratio -
Price/Sales (ttm) 65,844.5
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 2.21M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 43
Average volume (90 days) 462
Price summary
52-Week low 149.25
52-Week high 149.25
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 18 Jul 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -845%
Operational effectiveness
Return on assets -1.41%
Return on equity -1.94%
Income Statement
Revenue (ttm) 5K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -4.18M
Diluted EPS (ttm) -2.2
Quarterly earnings growth (yoy) -0.25%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.45%
Book value per share (mrq) -
Cash Flow
Cash flow statement -3.27M
Levered free cash flow (LFCF) -4.18M
